MKI67 and neoplasm: Consistent with the above results, KDM5B knockdown reduced tumorigenesis in vivo, showing that BXPC-3 cells with KDM5B knockdown displayed reduced tumor growth rate, size and Ki67, CD133 positive cells, compared to the control group, respectively (Fig. 2G–I, M).